Bmi1, stem cells, and senescence regulation

Journal of Clinical Investigation

Volumn 113, Issue 2, 2004, Pages 175-179

  Park, In Kyung ^a   Morrison, Sean J ^a   Clarke, Michael F ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BMI1 GENE; CELL AGING; GENE; GENE REPRESSION; HUMAN; LONGEVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SENESCENCE; SIGNAL TRANSDUCTION; STEM CELL; ANIMAL; BIOLOGICAL MODEL; CELL LINE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; MUTATION; PHYSIOLOGY;

BMI1 PROTEIN, HUMAN; BMI1 PROTEIN, MOUSE; CDKN2A PROTEIN, MOUSE; NUCLEAR PROTEIN; ONCOPROTEIN; PROTEIN P14ARF; PROTEIN P16INK4A; REPRESSOR PROTEIN;

ANIMALS; CELL AGING; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P16; GENE EXPRESSION REGULATION; HUMANS; MICE; MODELS, BIOLOGICAL; MUTATION; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; STEM CELLS; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 1342289563     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200420800     Document Type: Review

References (58)

1. Reya, T., Morrison, S., Clarke, M., and Weissman, I. 2001. Stem cells, cancer, and cancer stem cells. Nature. 414:105-111.
2. Till, J., and McCulloch, E. 1961. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat. Res. 14:1419-1430.
3. Williams, D., Lemischka, I., Nathan, D., and Mulligan, R. 1984. Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouse. Nature. 310:476-480.
4. Spangrude, G.J., Heimfeld, S., and Weissman, I.L. 1988. Purification and characteristics of mouse hematopoietic stem cells. Science. 241:58-62.
5. Morrison, S.J., and Weissman, I.L. 1994. The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity. 1:661-673.
6. Stemple, D., and Anderson, D. 1992. Isolation of a stem cell for neurons and glia from the mammalian neural crest. Cell. 71:973-985.
7. Davis, A., and Temple, S. 1994. A self-renewing multipotential stem cell in embryonic rat cerebral cortex. Nature. 372:263-266.
8. Domen, J., Cheshier, S.H., and Weissman, I.L. 2000. The role of apoptosis in the regulation of hematopoietic stem cells: overexpression of BCL-2 increases both their number and repopulation potential. J. Exp. Med. 191:253-264.
9. Lemischka, I.R., and Moore, K.A. 2003. Stem cells: interactive niches. Nature. 425:778-779.
10. Calvi, L.M., et al. 2003. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature. 425:841-846.
11. Zhang, J., et al. 2003. Identification of the haematopoietic stem cell niche and control of the niche size. Nature. 425:836-841.
12. Ogryzko, V., Hirai, T., Russanova, V., Barbie, D., and Howard, B. 1996. Human fibroblast commitment to a senescence-like state in response to histone deacetylase inhibitors is cell cycle dependent. Mol. Cell. Biol. 16:5210-5218.
13. Howard, B. 1996. Replicative senescence: considerations relating to the stability of heterochromatin domains. Exp. Gerontol. 31:281-293.
14. Villeponteau, B. 1997. The heterochromatin loss model of aging. Exp. Gerontol. 32:383-394.
15. Narita, M., et al. 2003. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell. 113:703-716.
16. Pathak, S. 2002. Organ- and tissue-specific stem cells and carcinogenesis. Anticancer Res. 22:1353-1356.
17. Morrison, S., Prowse, K., Ho, P., and Weissman, I. 1996. Telomerase activity in hematopoietic cells is associated with self-renewal potential. Immunity. 5:207-216.
18. Yui, J., Chiu, C.-P., and Lansdorp, P.M. 1998. Telomerase activity in candidate stem cells from fetal liver and adult bone marrow. Blood. 91:3255-3262.
19. Allsopp, R.C., and Weissman, I.L. 2002. Replicative senescence of hematopoietic stem cells during serial transplantation: does telomere shortening play a role? Oncogene. 21:3270-3273.
20. Samper, E., et al. 2002. Long-term repopulating ability of telomerase-deficient murine hematopoietic stem cells. Blood. 99:2767-2775.
21. Allsopp, R.C., Morin, G.B., DePinho, R., Harley, C.B., and Weissman, I.L. 2003. Telomerase is required to slow telomere shortening and extend replicative lifespan of HSCs during serial transplantation. Blood. 102:517-520.
22. Simon, J., and Tamkun, J. 2002. Programming off and on states in chromatin: mechanisms of Polycomb and trithorax group complexes. Curr. Opin. Genet. Dev. 12:210-218.
23. Orlando, V. 2003. Polycomb, epigenomes, and control of cell identity. Cell. 112:599-606.
24. Lessard, J., Baban, S., and Sauvageau, G. 1999. Stage-specific expression of Polycomb group genes in human bone marrow cells. Blood. 91:1216-1224.
25. Park, I.-K., et al. 2003. Bmi1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature. 423:302-305.
26. Molofsky, A.V., et al. 2003. Bmi1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature. 425:962-967.
27. Haupt, Y., Bath, M., Harris, A., and Adams, J. 1993. Bmi1 transgene induces lymphomas and collaborates with myc in tumorigenesis. Oncogene. 8:316-314.
28. Jacob, J., Kieboom, K., Marino, S., Depinho, R., and van Lohuizen, M. 1999. The oncogene and Polycomb-group gene Bmi1 regulates cell proliferation and senescence through the ink4a locus. Nature. 397:164-168.
29. van Lohuizen, M., et al. 1991. Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging. Cell. 65:737-752.
30. Alkema, M., Jacobs, H., van Lohuizen, M., and Berns, A. 1997. Pertubation of B and T cell development and predisposition to lymphomagenesis in Emu Bmi1 transgenic mice require the Bmi1 RING finger. Oncogene. 15:899-910.
31. van der Lugt, N.M., et al. 1994. Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the Bmi1 proto-oncogene. Genes Dev. 8:757-769.
32. Haupt, Y., Alexander, W., Barri, G., Klinken, S., and Adams, J. 1991. Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in E mu-myc transgenic mice. Cell. 65:753-763.
33. Bea, S., et al. 2001. BMI1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas. Cancer Res. 61:2409-2412.
34. van Kemenade, F.J., et al. 2001. Coexpression of BMI1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma. Blood. 97:3896-3901.
35. Vonlanthen, S., et al. 2001. The Bmi1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression. Br. J. Cancer. 84:1372-1376.
36. Lessard, J., and Sauvageau, G. 2003. Bmi1 determines the proliferative capacity of normal and leukaemic stem cells. Nature. 423:255-260.
37. Itahana, K., et al. 2003. Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi1. Mol. Cell. Biol. 23:389-401.
38. Quelle, D.E., Zindy, F., Ashmun, R.A., and Sherr, C.J. 1995. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell. 84:993-1000.
39. Sharpless, N., and DePinho, R. 1999. The INK4A/ARF locus and its two gene products. Curr. Opin. Genet. Dev. 9:22-30.
40. Vernell, R., Helin, K., and Muller, H. 2003. Identification of target genes of the p16INK4A-pRB-E2F pathway. J. Biol. Chem. 278:46124-46137.
41. Weber, J.D., Taylor, L.J., Roussel, M.F., Sherr, C.J., and Bar-Sagi, D. 1999. Nucleolar Arf sequesters Mdm2 and activates p53. Nat. Cell Biol. 1:20-26.
42. Honda, R., and Yasuda, H. 1999. Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J. 18:22-27.
43. Mendez-Vidal, C., Wilhelm, M.T., Hellborg, F., Qian, W., and Wiman, K.G. 2002. The p53-induced mouse zinc finger protein wig-1 binds double-stranded RNA with high affinity. Nucleic Acids Res. 30:1991-1996.
44. TeKippe, M., Harrison, D.E., and Chen, J. 2003. Expansion of hematopoietic stem cell phenotype and activity in Trp53-null mice. Exp. Hematol. 31:521-527.
45. Dimri, G.P., et al. 2002. The Bmi1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. Cancer Res. 62:4736-4745.
46. Brenner, A., Stampfer, M., and Aldaz, C. 1998. Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation. Oncogene. 17:199-205.
47. Wong, D., Foster, S., Galloway, D., and Reid, B. 1999. Progressive region-specific de novo methylation of the p16 CpG island in primary human mammary epithelial cell strains during escape from M(0) growth arrest. Mol. Biol. Cell. 19:5642-5651.
48. Wu, K., et al. 1999. Direct activation of TERT transcription by c-MYC. Nat. Genet. 21:220-224.
49. Greenberg, R., et al. 1999. Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene. 18:1219-1226.
50. Schmitt, C. 2003. Senescence, apoptosis and therapy: cutting the lifelines of cancer. Nat. Rev. Cancer. 3:286-295.
51. Van Zant, G., and Liang, Y. 2003. The role of stem cells in aging. Exp. Hematol. 31:659-672.
52. Liang, Y., and Van Zant, G. 2003. Genetic control of stem-cell properties and stem cells in aging. Curr. Opin. Hematol. 10:195-202.
53. Geiger, H., True, J.M., de Haan, G., and Van Zant, G. 2001. Age- and stage-specific regulation patterns in the hematopoietic stem cell hierarchy. Blood. 98:2966-2972.
54. Morrison, S., Prowse, K., Ho, P., and Weissman, I. 1996. The aging of hematopoietic stem cells. Nat. Med. 2:1011-1016.
55. Sudo, K., Ema, H., Morita, Y., and Nakauchi, H. 2000. Age-associated characteristics of murine hematopoietic stem cells. J. Exp. Med. 192:1273-1280.
56. Kim, M., Moon, H.-B., and Spangrude, G.J. 2003. Major age-related changes of mouse hematopoietic stem/progenitor cells. Ann N. Y. Acad. Sci. 996:195-208.
57. Van Zant, G., Holland, B., Eldridge, P., and Chen, J. 1990. Genotype-restricted growth and aging patterns in hematopoietic stem cell populations of allophenic mice. J. Exp. Med. 171:1547-1565.
58. Chen, J., Astle, C.M., and Harrison, D.E. 2000. Genetic regulation of primitive hematopoietic stem cell senescence. Exp. Hematol. 28:442-450.